Tianjin TEDA Biomedical Engineering Company Limited (HKG:8189)

Hong Kong · Delayed Price · Currency is HKD

0.2500

0.00 (0.00%)

Oct 7, 2026, 11:24 AM HKT

Market Cap	533.48M -39.0%
Revenue (ttm)	684.13M +50.8%
Net Income	-85.65M
EPS	-0.04
Shares Out	2.13B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	200,000
Open	0.2500
Previous Close	0.2500
Day's Range	0.2500 - 0.2500
52-Week Range	0.1140 - 0.4150
Beta	-0.23
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 9, 2026

About HKG:8189

Tianjin TEDA Biomedical Engineering Company Limited, together with its subsidiaries, engages in the research, development, manufacture, and sale of biological compound fertilizer products in the People’s Republic of China. It operates through Fertiliser Products, and AI health & elderly care products and services segments. The company’s biological compound fertilizer products include active fertilizer, mixture with nitrogen, phosphorus, and potassium with various formulas. It also involved in the provision of integrated elderly and health care;... [Read more]

Industry Agricultural Inputs

Sector Materials

Founded 2000

Employees 273

Stock Exchange Hong Kong Stock Exchange

Ticker Symbol 8189

Full Company Profile

Financial Performance

In 2025, HKG:8189's revenue was 522.97 million, an increase of 35.67% compared to the previous year's 385.48 million. Losses were -90.82 million, 226.7% more than in 2024.

Financial numbers in CNY Financial Statements